269 related articles for article (PubMed ID: 7391842)
21. Evaluation of experimental liver tumors using fluorine-18-2-fluoro-2-deoxy-D-glucose PET.
Oya N; Nagata Y; Ishigaki T; Abe M; Tamaki N; Magata Y; Konishi J
J Nucl Med; 1993 Dec; 34(12):2124-9. PubMed ID: 8254399
[TBL] [Abstract][Full Text] [Related]
22. The synthesis of 2-[F-18]fluoro-2-deoxy-D-glucose using glycals: a reexamination.
Bida GT; Satyamurthy N; Barrio JR
J Nucl Med; 1984 Dec; 25(12):1327-34. PubMed ID: 6502255
[TBL] [Abstract][Full Text] [Related]
23. [Development of 18F-FDG ([F-18]-2-fluoro-2-deoxy-D-glucose) injection for imaging of tumor reflecting glucose metabolism--results of preclinical studies].
Ino S; Shimada T; Kanagawa M; Suzuki N; Kondo S; Shirakami Y; Ito O; Kato-Azuma M
Kaku Igaku; 1999 Jul; 36(5):467-76. PubMed ID: 10466310
[TBL] [Abstract][Full Text] [Related]
24. A comparison of 131I-labeled antibodies, 2-deoxy-2-[18F]fluoro-D-glucose and 68Ga-EDTA in the imaging of human tumor xenografts in nude mice.
Brownell AL; Karonen SL; Korpela H; Lindroth L; Aaltonen J; Nikkinen P; Lindgren J
Int J Rad Appl Instrum B; 1990; 17(3):281-6. PubMed ID: 2111298
[TBL] [Abstract][Full Text] [Related]
25. Serum glucose: effects on tumor and normal tissue accumulation of 2-[F-18]-fluoro-2-deoxy-D-glucose in rodents with mammary carcinoma.
Wahl RL; Henry CA; Ethier SP
Radiology; 1992 Jun; 183(3):643-7. PubMed ID: 1584912
[TBL] [Abstract][Full Text] [Related]
26. 18f-fluorodeoxyglucose method for measuring local cerebral glucose metabolism in man: technique and results.
Reivich M; Alavi A; Greenberg J; Farkas T; Wolf A
Prog Nucl Med; 1981; 7():138-48. PubMed ID: 7323304
[No Abstract] [Full Text] [Related]
27. Assessment of the [18F]fluorodeoxyglucose kinetic model in calculations of myocardial glucose metabolism during ischemia.
Marshall RC; Huang SC; Nash WW; Phelps ME
J Nucl Med; 1983 Nov; 24(11):1060-4. PubMed ID: 6631527
[TBL] [Abstract][Full Text] [Related]
28. Assessment of radiotherapeutic effects on experimental tumors using 18F-2-fluoro-2-deoxy-D-glucose.
Abe Y; Matsuzawa T; Fujiwara T; Fukuda H; Itoh M; Yamada K; Yamaguchi K; Sato T; Ido T
Eur J Nucl Med; 1986; 12(7):325-8. PubMed ID: 3792361
[TBL] [Abstract][Full Text] [Related]
29. Metabolic pathway of 2-deoxy-2-fluoro-D-glucose studied by F-19 NMR.
Kanazawa Y; Momozono Y; Ishikawa M; Yamada T; Yamane H; Haradahira T; Maeda M; Kojima M
Life Sci; 1986 Aug; 39(8):737-42. PubMed ID: 3736344
[TBL] [Abstract][Full Text] [Related]
30. The radiation dosimetry of 2 [F-18]fluoro-2-deoxy-D-glucose in man.
Jones SC; Alavi A; Christman D; Montanez I; Wolf AP; Reivich M
J Nucl Med; 1982 Jul; 23(7):613-7. PubMed ID: 6979616
[TBL] [Abstract][Full Text] [Related]
31. Re: The radiation dosimetry of 2-[F-18]fluoro-2-deoxy-D-glucose in man.
Smith T
J Nucl Med; 1983 May; 24(5):447-8. PubMed ID: 6842294
[No Abstract] [Full Text] [Related]
32. Synthesis of no-carrier-added fluorine- 18 2-fluoro-2-deoxy-D-glucose.
Tewson TJ
J Nucl Med; 1983 Aug; 24(8):718-21. PubMed ID: 6683752
[TBL] [Abstract][Full Text] [Related]
33. Insulin-induced hypoglycemia decreases uptake of 2-[F-18]fluoro-2-deoxy-D-glucose into experimental mammary carcinoma.
Torizuka T; Fisher SJ; Wahl RL
Radiology; 1997 Apr; 203(1):169-72. PubMed ID: 9122387
[TBL] [Abstract][Full Text] [Related]
34. [Experimental study for cancer diagnosis with 18FDG: differential diagnosis of inflammation from malignant tumor].
Fukuda H; Yoshioka S; Watanuki S; Kiyosawa M; Sato T; Matsuzawa T; Takahashi T; Ido T
Kaku Igaku; 1983 Sep; 20(8):1189-92. PubMed ID: 6672371
[No Abstract] [Full Text] [Related]
35. [Comparative distribution study of 14C labeled amino acids, glucose-analogue and precursor of nuclei acid, as tumor seeking agents].
Shiba K; Mori H; Hisada K
Radioisotopes; 1984 Aug; 33(8):526-32. PubMed ID: 6505304
[TBL] [Abstract][Full Text] [Related]
36. [Autoradiographic demonstration of 18F-FDG distribution within mouse FM3A tumor tissue in vivo].
Kubota R; Yamada S; Kubota K; Ishiwata K; Tamahashi N; Ido T
Kaku Igaku; 1992 Oct; 29(10):1215-21. PubMed ID: 1464961
[TBL] [Abstract][Full Text] [Related]
37. Efficient stereospecific synthesis of no-carrier-added 2-[18F]-fluoro-2-deoxy-D-glucose using aminopolyether supported nucleophilic substitution.
Hamacher K; Coenen HH; Stöcklin G
J Nucl Med; 1986 Feb; 27(2):235-8. PubMed ID: 3712040
[TBL] [Abstract][Full Text] [Related]
38. Simple synthesis of F-18-labeled 2-fluoro-2-deoxy-D-glucose: concise communication.
Ehrenkaufer RE; Potocki JF; Jewett DM
J Nucl Med; 1984 Mar; 25(3):333-7. PubMed ID: 6699724
[TBL] [Abstract][Full Text] [Related]
39. [153Sm]citrate for tumor and abscess localization.
Woolfenden JM; Hall JN; Barber HB; Wacks ME
Int J Nucl Med Biol; 1983; 10(4):251-6. PubMed ID: 6582054
[No Abstract] [Full Text] [Related]
40. Positron imaging feasibility studies. II: Characteristics of 2-deoxyglucose uptake in rodent and canine neoplasms: concise communication.
Larson SM; Weiden PL; Grunbaum Z; Kaplan HG; Rasey JS; Graham MM; Sale GE; Harp GD; Williams DL
J Nucl Med; 1981 Oct; 22(10):875-9. PubMed ID: 6974768
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
